Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

NCT05768503 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Microsatellite-stable Colorectal Cancer

Interventions

DRUG: Experimental drug
DRUG: Control Rx

Sponsor

Sun Yat-sen University